Navigation Links
Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Date:12/15/2009

NEW YORK, Dec. 15 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html

Summary

The author has released its latest research "The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis." The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global respiratory diseases therapeutics market. The report analyzes the markets for respiratory disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

The scope of this report includes:

- Annualized market data for the respiratory diseases therapeutics market from 2000 to 2008, forecast forward to 2015

- Analysis of the leading therapeutic segments including asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension and cystic fibrosis

- Analysis of the respiratory diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan

- Market characterization of the respiratory diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns

- Key drivers and barriers that have a significant impact on the market

- Coverage of pipeline molecules in various phases of drug development

- Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, AstraZeneca and Merck & Co

- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global respiratory diseases therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to

- Align product portfolio to the markets with high growth potential

- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth

- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety

- Develop key strategic initiatives by understanding key focus areas of leading companies

- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Global Respiratory Therapeutics Market : Scope of Research

2.1 Introduction

2.2 GBI Research Report Guidance

3 Global Respiratory Therapeutics Market : Market Characterization

3.1 Market Forecasts

3.2 Branded Vs Generics

3.3 Average Cost of Therapy

3.4 Volume

3.5 Usage Patterns

3.5.1 Diseased Population

3.5.2 Treatment Seeking Population

3.5.3 Diagnosed Population

3.5.4 Prescription Population

3.5.5 Usage Patterns

3.5.6 Global Revenue Distribution Indication Wise

4 Global Asthma Therapeutics Market

4.1 Market Forecasts

4.2 Average Cost of Therapy

4.3 Volume

4.4 Usage Patterns

4.4.1 Diseased Population

4.4.2 Treatment Seeking Population

4.4.3 Diagnosed Population

4.4.4 Prescription Population

4.4.5 Usage Patterns

5 Global COPD Therapeutics Market

5.1 Market Forecasts

5.2 Average Cost of Therapy

5.3 Volume

5.4 Usage Patterns

5.4.1 Diseased Population

5.4.2 Treatment Seeking Population

5.4.3 Diagnosed Population

5.4.4 Prescription Population

5.4.5 Usage Patterns

6 Global Pulmonary Hypertension Therapeutics Market

6.1 Market Forecasts

6.2 Volume

6.3 Average Cost of Therapy

6.4 Usage Patterns

6.4.1 Diseased Population

6.4.2 Treatment Seeking Population

6.4.3 Diagnosed Population

6.4.4 Prescription Population

6.4.5 Usage Patterns

7 Global Cystic Fibrosis Therapeutics Market

7.1 Market Forecasts

7.2 Volume

7.3 Average Cost of Therapy

7.4 Usage Patterns

7.4.1 Diseased Population

7.4.2 Treatment Seeking Population

7.4.3 Diagnosed Population

7.4.4 Prescription Population

7.4.5 Usage Patterns

8 Global Respiratory Therapeutics Market : Market Drivers and Restraints

8.1 Market Drivers

8.1.1 Steady Increase in the Smoking Population

8.1.2 Stable Increase in Incidence Rates for Respiratory Diseases Disorders

8.1.3 Increase in Awareness Levels of Disease Progression and Etiology

8.2 Market Restraints

8.2.1 Patent Expirations and Entry of Generics Pose a Serious Problem for Primary Manufacturers

8.2.2 Reimbursement Restrictions on Drug Classes for Certain Respiratory Diseases Drug Classes Restricts the Market Growth

8.3 Global Respiratory Therapeutics Market: Unmet Needs

8.4 Global Respiratory Therapeutics Market: Key Market Trends

8.5 Increase in Disease Incidence and Prevalence Rates

8.6 Product Pipeline

8.7 Advertising and Commercialization

8.8 Regulatory Trends - Current Reimbursement Scenario

8.8.1 The Budget Impact on Drug Reimbursements

8.8.2 Reliability on Generic Formulations as a Cost Cutting Measure

9 Global Respiratory Therapeutics Market : Competitive Landscape

9.1 Overview

9.2 Market Share Analysis

9.3 Competitive Profiling

9.3.1 GlaxoSmithKline (GSK)

9.3.2 AstraZeneca

9.3.3 Merck

9.3.4 Novartis

10 Global Respiratory Therapeutics Market : Strategic Consolidations

10.1 Mergers and Acquisitions

10.1.1 Overview

10.2 Licensing Agreements

10.2.1 Approval

10.2.2 Filed

10.2.3 Phase III

10.2.4 Phase II

10.2.5 Pre-clinical

10.2.6 Discovery

11 Global Respiratory Therapeutics Market : Appendix

11.1 Market Definitions

11.2 Abbreviations

11.3 Research Methodology

11.3.1 Coverage

11.3.2 Secondary Research

11.3.3 Primary Research

11.3.4 Forecasts

11.3.5 Expert Panel Validation

11.4 Contact Us

11.5 Disclaimer

1.1 List of Tables

Table 1: Global Respiratory Therapeutics Market, Historical Revenues ($m), 2000-2008

Table 2: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2008-2015

Table 3: Global Respiratory Therapeutics Market, Revenue ($bn) Segmentation, 2000-2008

Table 4: Global Respiratory Therapeutics Market, Revenue Segmentation, 2008-2015

Table 5: Global Respiratory Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015

Table 6: Global Respiratory Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008

Table 7: Global Respiratory Therapeutics Market, Historical Figures for Volume, 00-2008

Table 8: Global Respiratory Therapeutics Market, Forecasts for Volume, 2008-2015

Table 9: Global Respiratory Therapeutics Market, Historical Figures for Diseased Population, 2000-2008

Table 10: Global Respiratory Therapeutics Market, Forecasts for Diseased Population, 2008-2015

Table 11: Global Respiratory Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008

Table 12: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015

Table 13: Global Respiratory Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008

Table 14: Global Respiratory Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015

Table 15: Global Respiratory Therapeutics Market, Historical Figures for Prescription Population, 2000-2008,

Table 16: Global Respiratory Therapeutics Market, Forecasts for Prescription Population, 2008-2015

Table 17: Global Respiratory Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008

Table 18: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2008-2015, November 2009

Table 19: Global Asthma Therapeutics Market, Historical Revenues ($bn), 2000-2008

Table 20: Global Asthma Therapeutics Market, Revenue Forecasts ($bn), 2008-2015

Table 21: Global Asthma Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008

Table 22: Global Asthma Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015

Table 23: Global Asthma Therapeutics Market, Historical Figures for Volume, 2000-2008

Table 24: Global Asthma Therapeutics Market, Forecasts for Volume, 2008-2015, November 2009

Table 25: Global Asthma Therapeutics Market, Historical Figures for Diseased Population, 2000-2008

Table 26: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2008-2015

Table 27: Global Asthma Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008

Table 28: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015

Table 29: Global Asthma Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008

Table 30: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015

Table 31: Global Asthma Therapeutics Market, Historical Figures for Prescription Population, 2000-2008

Table 32: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2008-2015

Table 33: Global Asthma Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008,

Table 34: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2008-2015,

Table 35: Global COPD Therapeutics Market, Historical Revenues ($m), 2000-2008

Table 36: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2008-2015

Table 37: Global COPD Therapeutics Market, Historical Figures for the Average Cost of Therapy ($), 2000-2008

Table 38: Global COPD Therapeutics Market, Forecast Figures for the Average Cost of Therapy ($), 2008-2015

Table 39: Global COPD Therapeutics Market, Historical Figures for Volume, 2000-2008, November 2009

Table 40: Global COPD Therapeutics Market, Forecasts for Volume, 2008-2015, November 2009

Table 41: Global COPD Therapeutics Market, Historical Figures for Diseased Population, 2000-2008

Table 42: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2008-2015

Table 43: Global COPD Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008

Table 44: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015

Table 45: Global COPD Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008

Table 46: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015, November 2009

Table 47: Global COPD Therapeutics Market, Historical Figures for Prescription Population, 2000-2008

Table 48: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2008-2015

Table 49: Global COPD Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008

Table 50: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2008-2015

Table 51: Global Pulmonary Hypertension Therapeutics Market, Historical Revenues ($m), 2000-2008

Table 52: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m), 2008-2015

Table 53: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Volume, 2000-2008

Table 54: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Volume, 2008-2015

Table 55: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008

Table 56: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015

Table 57: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diseased Population, 2000-2008

Table 58: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2008-2015

Table 59: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008

Table 60: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015

Table 61: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008

Table 62: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015

Table 63: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Prescription Population, 2000-2008

Table 64: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2008-2015

Table 65: Global Pulmonary Hypertension Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008

Table 66: Global Cystic Fibrosis Therapeutics Market, Historical Revenues ($m), 2000-2008

Table 67: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2008-2015

Table 68: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Volume, 2000-2008

Table 69: Global Cystic Fibrosis Therapeutics Market, Forecasts for Volume, 2008-2015

Table 70: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Average Cost of Therapy ($), 2000-2008

Table 71: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2008-2015

Table 72: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diseased Population, 2000-2008

Table 73: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population, 2008-2015

Table 74: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Treatment Seeking Population, 2000-2008

Table 75: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2008-2015

Table 76: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Diagnosed Population, 2000-2008

Table 77: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population, 2008-2015

Table 78: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Prescription Population, 2000-2008

Table 79: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2008-2015

Table 80: Global Cystic Fibrosis Therapeutics Market, Historical Figures for Usage Patterns, 2000-2008

Table 81: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2008-2015

Table 82: Global Respiratory Therapeutics Market, Market Drivers, 2008

Table 83: Global Respiratory Therapeutics Market, Major Drug Patent Expirations, 2008-2015

Table 84: Global Respiratory Therapeutics Market, Licensing Agreements for Approved Drugs, 2008-09

Table 85: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the NDA/BLA Filed Stage, 2008-09

Table 86: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase III Stage, 2008-09

Table 87: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Phase II Stage, 2008-2009

Table 88: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Pre-Clinical Stage, 2008-2009, November 2009

Table 89: Global Respiratory Therapeutics Market, Licensing Agreements for Drugs in the Discovery Stage, 2008-2009, November 2009

1.2 List of Figures

Figure 1: Global Respiratory Therapeutics Market, Revenue Forecasts ($m), 2000-2015

Figure 2: Global Respiratory Therapeutics Market, Revenue Segmentation, 2000-2015

Figure 3: Global Respiratory Therapeutics Market, Average Cost of Therapy ($), 2000-2015

Figure 4: Global Respiratory Therapeutics Market, Volume, 2000-2015

Figure 5: Global Respiratory Therapeutics Market, Diseased Population, 2000-2015

Figure 6: Global Respiratory Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015

Figure 7: Global Respiratory Therapeutics Market, Global Forecasts for Diagnosed Population, 2000-2015

Figure 8: Global Respiratory Therapeutics Market, Forecasts for Prescription Population, 2000-2015

Figure 9: Global Respiratory Therapeutics Market, Forecasts for Usage Patterns, 2000-2015,

Figure 10: Global Respiratory Therapeutics Market, , Revenue Distribution Indication Wise ($m), 2000-2015

Figure 11: Global Asthma Therapeutics Market, Revenue Forecasts ($m), 2000-2015

Figure 12: Global Asthma Therapeutics Market, Average Cost of Therapy ($), 2000-2015

Figure 13: Global Asthma Therapeutics Market, Volume, 2000-2015

Figure 14: Global Asthma Therapeutics Market, Forecasts for Diseased Population, 2000-2015

Figure 15: Global Asthma Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015

Figure 16: Global Asthma Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015,

Figure 17: Global Asthma Therapeutics Market, Forecasts for Prescription Population, 2000-2015

Figure 18: Global Asthma Therapeutics Market, Forecasts for Usage Patterns, 2000-2015

Figure 19: Global COPD Therapeutics Market, Revenue Forecasts ($m), 2000-2015

Figure 20: Global COPD Therapeutics Market, Average Cost of Therapy ($), 2000-2015

Figure 21: Global COPD Therapeutics Market, Volume, 2000-2015

Figure 22: Global COPD Therapeutics Market, Forecasts for Diseased Population, 2000-2015

Figure 23: Global COPD Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015

Figure 24: Global COPD Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015

Figure 25: Global COPD Therapeutics Market, Forecasts for Prescription Population, 2000-2015

Figure 26: Global COPD Therapeutics Market, Forecasts for Usage Patterns, 2000-2015

Figure 27: Global Pulmonary Hypertension Therapeutics Market, Revenue Forecasts ($m), 2000-2015

Figure 28: Global Pulmonary Hypertension Therapeutics Market, Volume, 2000-2015

Figure 29: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015

Figure 30: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diseased Population, 2000-2015

Figure 31: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015

Figure 32: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015

Figure 33: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Prescription Population, 2000-2015

Figure 34: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2000-2015

Figure 35: Global Pulmonary Hypertension Therapeutics Market, Forecasts for Usage Patterns, 2008-2015

Figure 36: Global Cystic Fibrosis Therapeutics Market, Revenue Forecasts ($m), 2000-2015

Figure 37: Global Cystic Fibrosis Therapeutics Market, Volume, 2000-2015

Figure 38: Global Cystic Fibrosis Therapeutics Market, Forecasts for Average Cost of Therapy ($), 2000-2015

Figure 39: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diseased Population, 2000-2015

Figure 40: Global Cystic Fibrosis Therapeutics Market, Forecasts for Treatment Seeking Population, 2000-2015

Figure 41: Global Cystic Fibrosis Therapeutics Market, Forecasts for Diagnosed Population, 2000-2015

Figure 42: Global Cystic Fibrosis Therapeutics Market, Forecasts for Prescription Population, 2000-2015

Figure 43: Global Cystic Fibrosis Therapeutics Market, Forecasts for Usage Patterns, 2000-2015

Figure 44: Global Respiratory Therapeutics Market, Market Indicators, 2008, November 2009

Figure 45: Global Respiratory Therapeutics Market, Market Restraints, 2008

Figure 46: Global Respiratory Therapeutics Market, Analysis of Unmet Needs for Major Disease Sectors, 2008

Figure 47: Global Respiratory Therapeutics Market, Key Market Events, 2008-2015

Figure 48: Global Respiratory Therapeutics Market, Market Share of Top Manufacturers, 2008

Figure 49: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers, 2008

Figure 50: Respiratory Therapeutics Market, Global Benchmarking Analysis for the Top Four Manufacturers (Cont..), 2008

Figure 51: Global Respiratory Therapeutics Market, M&A Deals by Geography, 2008

Figure 52: Global Respiratory Therapeutics Market, M&A Deals by Deal Size, 2008

Figure 53: Global Respiratory Therapeutics Market, M&A Deals by Phase, 2008

Figure 54: Global Respiratory Therapeutics Market, Top Three M&A Deals, 2008

Figure 55: Global Respiratory Therapeutics Market, Licensing Agreements by Geography, 2008

Figure 56: Global Respiratory Therapeutics Market, Licensing Agreements by Deal Size, 2008

Figure 57: Global Respiratory Therapeutics Market, Licensing Agreements by Phases of Development, 2008

Figure 58: Global Respiratory Therapeutics Market, Licensing Agreements by Indications, 2008, November 2009

Figure 59: GBI Research Methodology

Figure 60: Global Respiratory Therapeutics Market Forecasting Model

Companies mentioned

GlaxoSmithKline (GSK)

AstraZeneca

Novartis

To order this report:

Respiratory Devices Industry: The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis

More Market Research Report


    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)-652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: